Integrated rare variant-based risk gene prioritization in disease case-control sequencing studies

Research output: Contribution to journalArticle

4 Scopus citations

Abstract

Rare variants of major effect play an important role in human complex diseases and can be discovered by sequencing-based genome-wide association studies. Here, we introduce an integrated approach that combines the rare variant association test with gene network and phenotype information to identify risk genes implicated by rare variants for human complex diseases. Our data integration method follows a 'discovery-driven' strategy without relying on prior knowledge about the disease and thus maintains the unbiased character of genome-wide association studies. Simulations reveal that our method can outperform a widely-used rare variant association test method by 2 to 3 times. In a case study of a small disease cohort, we uncovered putative risk genes and the corresponding rare variants that may act as genetic modifiers of congenital heart disease in 22q11.2 deletion syndrome patients. These variants were missed by a conventional approach that relied on the rare variant association test alone.

Original languageEnglish (US)
Article numbere1007142
JournalPLoS genetics
Volume13
Issue number12
DOIs
StatePublished - Dec 2017

ASJC Scopus subject areas

  • Ecology, Evolution, Behavior and Systematics
  • Molecular Biology
  • Genetics
  • Genetics(clinical)
  • Cancer Research

Fingerprint Dive into the research topics of 'Integrated rare variant-based risk gene prioritization in disease case-control sequencing studies'. Together they form a unique fingerprint.

  • Cite this